Blockade of nitric oxide decreases the renal vasodilatory effect of neuropeptide Y in the insulin-treated diabetic rat

Pflugers Archiv European Journal of Physiology

Volumn 434, Issue 4, 1997, Pages 445-450

  Torffvit, O ^a   Edvinsson, L ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Trinositol; Calcitonin gene related peptide; Diabetes; Endothelin 1; N(G) Nitro L arginine methyl ester; Renal vasculature; Vasoactive intestinal peptide

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; ENDOTHELIN 1; INSULIN; N(G) NITROARGININE METHYL ESTER; NEUROPEPTIDE Y; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM; SEROTONIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; MALE; NEUROPEPTIDE Y; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 0030769556     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240050419     Document Type: Article

References (49)

1. Harris RD, Steffes MW, Bilous RW, Sutherland DER, Mauer SM (1991) Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40:107-114
2. Airaksinen KEJ, Salmela PI, Linnaluoto MK, Ikäheimo MJ, Ahola K, Ryhänen L J (1993) Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc Res 27:942-945
3. Platt JF, Rubin JM, Ellis JH (1994) Diabetic nephropathy: evaluation with renal duplex doppler US. Radiology 190:343-346
4. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438
5. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG (1994) Abnormalities in the renal and vascular responses to LBNP in humans with early diabetes. Am J Physiol 266:R442-R450
6. Tønder KJH, Aukland K (1979/80) Interlobular arterial pressure in the rat kidney. Renal Physiol 2:214-221
7. Heller J (1987) Effect of vasoactive mediators on renal haemodynamics. Nephrol Dial Transplant 2:197-204
8. Owen MP, Carrier GO (1979) Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes. Proc West Pharmacol Soc 22:363-366
9. G-nitro-arginine methyl ester in conscious rats. Br J Pharmacol 103:1256-1262
10. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5:161-166
11. Andersson D, Brunkwall J, Bergqvist D, Edvinsson L (1992) Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits. J Auton Nerv Syst 37:215-222
12. Torffvit O, Adamsson M, Edvinsson L (1997) Renal arterial activity to potassium, noradrenaline and neuropeptide Y and association with urinary albumin excretion in the diabetic rats. J Diabetes Complications (in press)
13. Gulbenkian S, Edvinsson L, Opgaard OS, Valenca A, Wharton J, Polak JM (1992) Neuropeptide Y modulates the action of vasodilator agents in guinea-pig epicardial coronary arteries. Regul Pept 40:351-362
14. Edvinsson L, Adamsson M (1992) Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate. J Cardiovasc Pharmacol 20:466-472
15. Adamsson M, Fallgren B, Edvinsson L (1992) Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Br J Pharmacol 105:93-96
16. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S (1991) Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 88:390-395
17. Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO (1995) Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia 38:525-535
18. Bank N, Aynedjian HS (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312
19. G-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension 15:659-663
20. Bhardwaj R, Moore PK (1988) Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 40:739-742
21. Sjögren A, Edvinsson L (1988) Vasomotor changes in isolated coronary arteries from diabetic rats. Acta Physiol Scand 134:429-436
22. Högestätt ED, Andersson K-E, Edvinsson L (1983) Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand 117:49-61
23. G-Monomethyl-L-arginine on the onset of diabetes in the spontaneously diabetic BB rat. Diabetes 44:360-364
24. Komers R, Allen TJ, Cooper ME (1994) Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197
25. Yamada K, Nakano H, Nakayama M, Nozaki O, Miura Y, Nishimura M, Tsuchida H, Mimura N (1995) Endothelium-dependent relaxation in peripheral vasculature and kidney of non-insulin-dependent diabetes mellitus. J Diabetes Complications 9:203-207
26. Opgaard OS, Adner M, Gulbenkian S, Edvinsson L (1994) Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 23:576-583
27. Tammesild PJ, Hodgson WC, King RG (1992) Increased sensitivity to endothelin-1 in isolated krebs'-perfused kidneys of streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 19:261-265
28. Smulders RA, Stehouwer CDA, Olthof CG, van Kamp GJ, Teerlink T, de Vries PMJM, Donker AJM (1994) Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 87:37-43
29. Lee Y-J, Shin S-J, Tsai J-H (1994) Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17:263-266
30. Blöchl-Daum B, Vierhapper H, Eichler H-G, Waldhäusl W (1992) Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins. Arch Int Pharmacodyn 316:90-96
31. Gulbenkian S, Opgaard OS, Ekman R, Andrade NC, Wharton J, Polak JM, Melo JQ, Edvinsson L (1993) Peptidergic innervation of human epicardial coronary arteries. Circulation Res 73:579-588
32. Edvinsson L, Håkanson R, Steen S, Sundler F, Uddman R, Wahlestedt C (1985) Innervation of human omental arteries and veins and vasomotor responses to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide. Regul Pept 12:67-79
33. Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J, Stiernholm P, Edvinsson L (1986) Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 20:496-501
34. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C (1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 58:213-217
35. Dimaline R, Peart WS, Unwin RJ (1983) Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit. J Physiol (Lond) 344:379-388
36. Cairns HS, Rogerson ME, Westwick J, Neild GH (1991) Regional heterogeneity of endothelium-dependent vasodilatation in the rabbit kidney. J Physiol (Lond) 436:421-429
37. Fortes ZB, Lerne JG, Scivoletto R (1983) Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol 79:771-781
38. Hattori Y, Kawasaki H, Abe K, Kanno M (1991) Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094
39. Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648
40. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM (1993) Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci 85:687-693
41. Griffiths MJD, Messent M, MacAllister RJ, Evans TW (1993) Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110:963-968
42. Hackenthal E, Aktories K, Jakobs KH, Lang RE (1987) Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol 252:F543-F550
43. Ahlborg G, Weitzberg E, Lundberg JM (1992) Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans. Clin Physiol 12:145-153
44. Edvinsson L, Emson P, McCulloch J, Tatemoto K, Uddman R (1984) Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. Acta Physiol Scand 122:155-163
45. Burnstock G (1990) Overview: purinergic mechanisms. Ann NY Acad Sci 603:1-17
46. Wahlestedt C, Edvinsson L, Ekblad E, Håkanson R (1985) Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther 234:735-741
47. You J, Zhang W, Jansen-Olesen I, Edvinsson L (1995) Relation between cyclic GMP generation and cerebrovascular reactivity: modulation by NPY and α-trinositol. Pharmacol Toxicol 77:48-56
48. 1 receptors is inhibited by L-NMMA. In: Lind H (ed) Neuropeptide Y (NPY) - aspects of vasomotor response and haemodynamics in hypertension and non-insulin-dependent diabetes mellitus. Doctoral dissertation, University of Lund, Sweden, pp 156-167
49. Mauer SM, Azar S, Steffes MW, Brown DM (1994) The effects of normalization of dietary protein intake and carotid artery ligation on the renal autoregulatory abnormalities of streptozotocin diabetic rats. J Diab Comp 8:89-96